Sign Up to like & get
recommendations!
1
Published in 2022 at "Current Medical Research and Opinion"
DOI: 10.1080/03007995.2022.2033011
Abstract: Abstract Objective Cost-effectiveness analyses that consider all currently used antiemetics in the case of emetogenic chemotherapy-induced nausea and vomiting (CINV) have not been performed yet. We aim to compare the cost-effectiveness of olanzapine (OLA), or/and…
read more here.
Keywords:
pal dex;
nausea;
dex;
ola ... See more keywords
Sign Up to like & get
recommendations!
3
Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-ct188
Abstract: Background: PARP inhibitors (PARPi) are superior to chemotherapy in pts with BRCA1/2m MBC, with median PFS (mPFS) of 7 months with single-agent ola. Sapa is an oral nucleoside analog; the active metabolite, CNDAC, generates single-strand…
read more here.
Keywords:
pts brca1;
ola;
phase study;
cancer ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Polymers"
DOI: 10.3390/polym11122099
Abstract: This work reports the effect of the addition of an oligomer of lactic acid (OLA), in the 5–20 wt% range, on the processing and properties of polylactide (PLA) pieces prepared by injection molding. The obtained…
read more here.
Keywords:
addition;
shape memory;
ola;
memory behavior ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Clinical Psychopharmacology and Neuroscience"
DOI: 10.9758/cpn.2022.20.3.567
Abstract: Objective The purpose of this study was to compare the efficacy and tolerability of continued olanzapine (OLA) versus amisulpride (AMI) augmentation in schizophrenic patients with poor response to OLA monotherapy. Methods The present 4-week, randomized,…
read more here.
Keywords:
poor response;
patients poor;
ola;
augmentation ... See more keywords